RxDoctor Payments Data

Mary Wright, APRN

Family · Corning, ARNPI 1598422263

Payments from drug & device makers

$229in general payments, 2019–2025

Across 15 payments — averaging $15.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$118
  • AstraZeneca$19
  • Novo Nordisk$17
  • Boston Scientific$17
  • Sanofi$16
  • Lilly USA, LLC$16
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$229100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$229 in reported general payments places this provider in the 40th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$6,737
Medicare patients
111
Services billed
541

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin77$52,260
Trelegy ElliptaFluticasone/Umeclidin/Vilanter74$43,808
JanuviaSitagliptin Phosphate67$41,664
EliquisApixaban40$30,973
FarxigaDapagliflozin Propanediol18$12,243
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$10,006
SymbicortBudesonide/Formoterol Fumarate24$7,740
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$6,328
Breo ElliptaFluticasone/Vilanterol15$5,920
Advair HfaFluticasone Propion/Salmeterol14$5,623
Combivent RespimatIpratropium/Albuterol Sulfate12$5,193
Incruse ElliptaUmeclidinium Bromide14$4,602
Albuterol Sulfate HfaAlbuterol Sulfate119$3,025
Omeprazole167$2,137
Ventolin HfaAlbuterol Sulfate38$2,003

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Combivent Respimat$13$57,45389 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$118$54,330103 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$19$29,98956 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 2,103 family providers in Arkansas.

Other family in Corning

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →